These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1114 related articles for article (PubMed ID: 2510580)

  • 21. Antitumor activity of novel ailanthone derivatives in vitro and in vivo.
    Kato T; Suzumura Y; Fukushima M; Honda T; Nakanishi T; Noguchi T
    Anticancer Res; 1988; 8(4):573-9. PubMed ID: 3178149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymeric prodrugs of mitomycin C designed for tumour tropism and sustained activation.
    Seymour LW; Soyez H; De Marre A; Shoaibi MA; Schacht EH
    Anticancer Drug Des; 1996 Jul; 11(5):351-65. PubMed ID: 8765529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo characterization of P388 leukemia resistant to mitomycin C.
    Rose WC; Huftalen JB; Bradner WT; Schurig JE
    In Vivo; 1987; 1(1):47-52. PubMed ID: 2979764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and antineoplastic activity of mitosene analogues of the mitomycins.
    Hodges JC; Remers WA; Bradner WT
    J Med Chem; 1981 Oct; 24(10):1184-91. PubMed ID: 7328580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationships for mitomycin C and mitomycin A analogues.
    Kunz KR; Iyengar BS; Dorr RT; Alberts DS; Remers WA
    J Med Chem; 1991 Jul; 34(7):2281-6. PubMed ID: 1906109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitomycin C and porfiromycin analogues with substituted ethylamines at position 7.
    Iyengar BS; Sami SM; Remers WA; Bradner WT; Schurig JE
    J Med Chem; 1983 Jan; 26(1):16-20. PubMed ID: 6827524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines.
    Tsuruo T; Yusa K; Sudo Y; Takamori R; Sugimoto Y
    Cancer Res; 1989 Oct; 49(20):5537-42. PubMed ID: 2790778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antitumor activity of novel mitomycin derivatives containing functional groups at the C-6-methyl position.
    Arai H; Kanda Y; Ashizawa T; Morimoto M; Gomi K; Kono M; Kasai M
    J Med Chem; 1994 Jun; 37(12):1794-804. PubMed ID: 8021918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor effect of selected daunorubicin derivatives in mice with P 388 leukemia.
    Kuśnierczyk H; Rak J; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1986; 34(3):259-62. PubMed ID: 3592929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor activity of mitomycin C-dextran conjugate against various murine tumors.
    Hashida M; Kato A; Kojima T; Muranishi S; Sezaki H; Tanigawa N; Satomura K; Hikasa Y
    Gan; 1981 Apr; 72(2):226-34. PubMed ID: 6169584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Azinomycins A and B, new antitumor antibiotics. III. Antitumor activity.
    Ishizeki S; Ohtsuka M; Irinoda K; Kukita K; Nagaoka K; Nakashima T
    J Antibiot (Tokyo); 1987 Jan; 40(1):60-5. PubMed ID: 3104267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new antitumour agent, batracylin, selected by a preclinical solid tumour model.
    Atassi G; Dumont P; Kabbe HJ; Yoder O
    Drugs Exp Clin Res; 1988; 14(9):571-4. PubMed ID: 3229319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitomycin C analogues with a substituted hydrazine at position 7. Synthesis, spectral properties, and biological activity.
    Sawhney KN; Kohn H
    J Med Chem; 1989 Jan; 32(1):248-52. PubMed ID: 2909738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.
    Li LH; DeKoning TF; Wallace TL
    Cancer Res; 1987 Nov; 47(22):5894-900. PubMed ID: 3664490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor activity and nucleic acid binding properties of dercitin, a new acridine alkaloid isolated from a marine Dercitus species sponge.
    Burres NS; Sazesh S; Gunawardana GP; Clement JJ
    Cancer Res; 1989 Oct; 49(19):5267-74. PubMed ID: 2548717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental combination chemotherapy of pirarubicin with various antitumor drugs against P388 murine leukemia.
    Izumi H; Hirano S; Matsushita Y; Iguchi H; Tone H; Takeuchi T
    Cancer Biochem Biophys; 1994 Sep; 14(2):137-49. PubMed ID: 7889494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and in vivo antitumor activity of novel mitomycin A disulfide analogs.
    Vyas DM; Benigni D; Rose WC; Bradner WT; Doyle TW
    J Antibiot (Tokyo); 1989 Jul; 42(7):1199-201. PubMed ID: 2753826
    [No Abstract]   [Full Text] [Related]  

  • 38. Mitomycin C analogues with aryl substituents on the 7-amino group.
    Sami SM; Iyengar BS; Tarnow SE; Remers WA; Bradner WT; Schurig JE
    J Med Chem; 1984 May; 27(5):701-8. PubMed ID: 6425501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.
    Burres NS; Clement JJ
    Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.
    Berners-Price SJ; Mirabelli CK; Johnson RK; Mattern MR; McCabe FL; Faucette LF; Sung CM; Mong SM; Sadler PJ; Crooke ST
    Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.